Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Announces Clinical Data Presentations at ASCO 2016
April 21, 2016 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Announces Four Preclinical Presentations at the American Association for Cancer Research Annual Meeting 2016
April 18, 2016 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 18, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at the 15th Annual Needham Healthcare Conference
April 08, 2016 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 08, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Highlights
March 15, 2016 07:30 ET | Calithera Biosciences, Inc.
-CB-839 Combination Data submitted for Presentation at ASCO 2016 -IND to be submitted for Immuno-Oncology Candidate CB-1158 in mid-2016 -Calithera to Host Conference Call Today at 8:30 a.m....
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Report Fourth Quarter and Year-End 2015 Financial Results on Tuesday, March 15, 2016
March 08, 2016 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at Cowen and Company 36th Annual Health Care Conference
March 01, 2016 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at the BIO CEO & Investor and Leerink Global Healthcare Conferences in February
February 02, 2016 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Announces Abstract Selected for Oral Presentation at the 2016 Keystone Symposia
January 22, 2016 09:01 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Reports Phase I Data for CB-839 in Patients With Hematological Malignancies at the 57th American Society of Hematology Annual Meeting
December 06, 2015 10:25 ET | Calithera Biosciences, Inc.
First results of CB-839 dosed in combination therapy Promising clinical activity with early signs of biologic activity, tolerability, and durability SOUTH SAN FRANCISCO, Calif., Dec. 06, 2015 ...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Presents Preclinical Study Findings for CB-839 at the 2015 Novel Cancer Therapeutics Summit
November 16, 2015 16:06 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer...